Risk of dementia in propensity score-matched patients undergoing ablation or medical therapy
. | Number of events . | Event rate . | Number of events . | Event rate . | Absolute rate difference per 1000 person-years (95% CI) . | Adjusted hazard ratioa (95% CI) . | P-value . |
---|---|---|---|---|---|---|---|
Ablation vs. medical therapy | |||||||
Ablation (N = 5863) | Medical therapy (N = 5863) | ||||||
Including stroke | |||||||
Overall dementia | 164 | 5.6 | 308 | 8.1 | −2.5 (−3.8 to −1.2) | 0.73 (0.58–0.93) | <0.001 |
Alzheimer’s disease | 120 | 4.1 | 189 | 5.0 | −0.9 (−1.9 to 0.1) | 0.77 (0.61–0.97) | 0.030 |
Vascular dementia | 36 | 1.2 | 85 | 2.2 | −1.0 (−1.7 to −0.4) | 0.50 (0.33–0.74) | <0.001 |
Censoring for stroke | |||||||
Overall dementia | 134 | 4.7 | 217 | 5.9 | −1.3 (−2.4 to −0.1) | 0.76 (0.61–0.95) | 0.015 |
Alzheimer’s disease | 106 | 3.7 | 140 | 3.8 | −0.1 (−1.1 to 0.8) | 0.91 (0.71–1.18) | 0.490 |
Vascular dementia | 22 | 0.8 | 51 | 1.4 | −0.6 (−1.1 to −0.1) | 0.60 (0.36–0.98) | 0.041 |
Ablation vs. AAD | |||||||
Ablation (N = 3612) | AAD (N = 3612) | ||||||
Including stroke | |||||||
Overall dementia | 101 | 5.7 | 183 | 7.9 | −2.1 (−3.8 to −0.5) | 0.74 (0.57–0.94) | 0.015 |
Alzheimer’s disease | 77 | 4.4 | 118 | 5.1 | −0.7 (−2.1 to 0.7) | 0.89 (0.66–1.19) | 0.420 |
Vascular dementia | 20 | 1.1 | 49 | 2.1 | −1.0 (−1.8 to −0.2) | 0.57 (0.34–0.95) | 0.031 |
Censoring for stroke | |||||||
Overall dementia | 83 | 4.9 | 133 | 6.0 | −1.1 (−2.6 to 0.4) | 0.82 (0.62–1.08) | 0.160 |
Alzheimer’s disease | 67 | 3.9 | 94 | 4.2 | −0.3 (−1.6 to 1.0) | 0.96 (0.69–1.32) | 0.790 |
Vascular dementia | 13 | 0.8 | 28 | 1.3 | −0.5 (−1.1 to 0.2) | 0.54 (0.28–1.04) | 0.067 |
Ablation vs. rate control only | |||||||
Ablation (N = 1273) | Rate control only (N = 1273) | ||||||
Including stroke | |||||||
Overall dementia | 41 | 6.2 | 102 | 12.1 | −5.9 (−9.1 to −2.8) | 0.57 (0.40–0.83) | 0.003 |
Alzheimer’s disease | 33 | 5.0 | 64 | 7.6 | −2.6 (−5.2 to 0.0) | 0.75 (0.49–1.14) | 0.170 |
Vascular dementia | 6 | 0.9 | 25 | 3.0 | −2.1 (−3.5 to −0.6) | 0.33 (0.13–0.83) | 0.018 |
Censoring for stroke | |||||||
Overall dementia | 33 | 5.1 | 67 | 8.5 | −3.4 (−6.1 to −0.6) | 0.68 (0.45–1.03) | 0.072 |
Alzheimer’s disease | 29 | 4.5 | 45 | 5.7 | −1.2 (−3.6 to 0.1) | 0.89 (0.56–1.41) | 0.610 |
Vascular dementia | 3 | 0.5 | 13 | 1.6 | −1.2 (−2.3 to −0.1) | 0.33 (0.09–1.20) | 0.092 |
. | Number of events . | Event rate . | Number of events . | Event rate . | Absolute rate difference per 1000 person-years (95% CI) . | Adjusted hazard ratioa (95% CI) . | P-value . |
---|---|---|---|---|---|---|---|
Ablation vs. medical therapy | |||||||
Ablation (N = 5863) | Medical therapy (N = 5863) | ||||||
Including stroke | |||||||
Overall dementia | 164 | 5.6 | 308 | 8.1 | −2.5 (−3.8 to −1.2) | 0.73 (0.58–0.93) | <0.001 |
Alzheimer’s disease | 120 | 4.1 | 189 | 5.0 | −0.9 (−1.9 to 0.1) | 0.77 (0.61–0.97) | 0.030 |
Vascular dementia | 36 | 1.2 | 85 | 2.2 | −1.0 (−1.7 to −0.4) | 0.50 (0.33–0.74) | <0.001 |
Censoring for stroke | |||||||
Overall dementia | 134 | 4.7 | 217 | 5.9 | −1.3 (−2.4 to −0.1) | 0.76 (0.61–0.95) | 0.015 |
Alzheimer’s disease | 106 | 3.7 | 140 | 3.8 | −0.1 (−1.1 to 0.8) | 0.91 (0.71–1.18) | 0.490 |
Vascular dementia | 22 | 0.8 | 51 | 1.4 | −0.6 (−1.1 to −0.1) | 0.60 (0.36–0.98) | 0.041 |
Ablation vs. AAD | |||||||
Ablation (N = 3612) | AAD (N = 3612) | ||||||
Including stroke | |||||||
Overall dementia | 101 | 5.7 | 183 | 7.9 | −2.1 (−3.8 to −0.5) | 0.74 (0.57–0.94) | 0.015 |
Alzheimer’s disease | 77 | 4.4 | 118 | 5.1 | −0.7 (−2.1 to 0.7) | 0.89 (0.66–1.19) | 0.420 |
Vascular dementia | 20 | 1.1 | 49 | 2.1 | −1.0 (−1.8 to −0.2) | 0.57 (0.34–0.95) | 0.031 |
Censoring for stroke | |||||||
Overall dementia | 83 | 4.9 | 133 | 6.0 | −1.1 (−2.6 to 0.4) | 0.82 (0.62–1.08) | 0.160 |
Alzheimer’s disease | 67 | 3.9 | 94 | 4.2 | −0.3 (−1.6 to 1.0) | 0.96 (0.69–1.32) | 0.790 |
Vascular dementia | 13 | 0.8 | 28 | 1.3 | −0.5 (−1.1 to 0.2) | 0.54 (0.28–1.04) | 0.067 |
Ablation vs. rate control only | |||||||
Ablation (N = 1273) | Rate control only (N = 1273) | ||||||
Including stroke | |||||||
Overall dementia | 41 | 6.2 | 102 | 12.1 | −5.9 (−9.1 to −2.8) | 0.57 (0.40–0.83) | 0.003 |
Alzheimer’s disease | 33 | 5.0 | 64 | 7.6 | −2.6 (−5.2 to 0.0) | 0.75 (0.49–1.14) | 0.170 |
Vascular dementia | 6 | 0.9 | 25 | 3.0 | −2.1 (−3.5 to −0.6) | 0.33 (0.13–0.83) | 0.018 |
Censoring for stroke | |||||||
Overall dementia | 33 | 5.1 | 67 | 8.5 | −3.4 (−6.1 to −0.6) | 0.68 (0.45–1.03) | 0.072 |
Alzheimer’s disease | 29 | 4.5 | 45 | 5.7 | −1.2 (−3.6 to 0.1) | 0.89 (0.56–1.41) | 0.610 |
Vascular dementia | 3 | 0.5 | 13 | 1.6 | −1.2 (−2.3 to −0.1) | 0.33 (0.09–1.20) | 0.092 |
Event rates are per 1000 person-years.
Adjusted for clinical variables (listed in Table 1) and competing risk of all-cause deaths.
AAD, antiarrhythmic drug; CI, confidence interval.
Risk of dementia in propensity score-matched patients undergoing ablation or medical therapy
. | Number of events . | Event rate . | Number of events . | Event rate . | Absolute rate difference per 1000 person-years (95% CI) . | Adjusted hazard ratioa (95% CI) . | P-value . |
---|---|---|---|---|---|---|---|
Ablation vs. medical therapy | |||||||
Ablation (N = 5863) | Medical therapy (N = 5863) | ||||||
Including stroke | |||||||
Overall dementia | 164 | 5.6 | 308 | 8.1 | −2.5 (−3.8 to −1.2) | 0.73 (0.58–0.93) | <0.001 |
Alzheimer’s disease | 120 | 4.1 | 189 | 5.0 | −0.9 (−1.9 to 0.1) | 0.77 (0.61–0.97) | 0.030 |
Vascular dementia | 36 | 1.2 | 85 | 2.2 | −1.0 (−1.7 to −0.4) | 0.50 (0.33–0.74) | <0.001 |
Censoring for stroke | |||||||
Overall dementia | 134 | 4.7 | 217 | 5.9 | −1.3 (−2.4 to −0.1) | 0.76 (0.61–0.95) | 0.015 |
Alzheimer’s disease | 106 | 3.7 | 140 | 3.8 | −0.1 (−1.1 to 0.8) | 0.91 (0.71–1.18) | 0.490 |
Vascular dementia | 22 | 0.8 | 51 | 1.4 | −0.6 (−1.1 to −0.1) | 0.60 (0.36–0.98) | 0.041 |
Ablation vs. AAD | |||||||
Ablation (N = 3612) | AAD (N = 3612) | ||||||
Including stroke | |||||||
Overall dementia | 101 | 5.7 | 183 | 7.9 | −2.1 (−3.8 to −0.5) | 0.74 (0.57–0.94) | 0.015 |
Alzheimer’s disease | 77 | 4.4 | 118 | 5.1 | −0.7 (−2.1 to 0.7) | 0.89 (0.66–1.19) | 0.420 |
Vascular dementia | 20 | 1.1 | 49 | 2.1 | −1.0 (−1.8 to −0.2) | 0.57 (0.34–0.95) | 0.031 |
Censoring for stroke | |||||||
Overall dementia | 83 | 4.9 | 133 | 6.0 | −1.1 (−2.6 to 0.4) | 0.82 (0.62–1.08) | 0.160 |
Alzheimer’s disease | 67 | 3.9 | 94 | 4.2 | −0.3 (−1.6 to 1.0) | 0.96 (0.69–1.32) | 0.790 |
Vascular dementia | 13 | 0.8 | 28 | 1.3 | −0.5 (−1.1 to 0.2) | 0.54 (0.28–1.04) | 0.067 |
Ablation vs. rate control only | |||||||
Ablation (N = 1273) | Rate control only (N = 1273) | ||||||
Including stroke | |||||||
Overall dementia | 41 | 6.2 | 102 | 12.1 | −5.9 (−9.1 to −2.8) | 0.57 (0.40–0.83) | 0.003 |
Alzheimer’s disease | 33 | 5.0 | 64 | 7.6 | −2.6 (−5.2 to 0.0) | 0.75 (0.49–1.14) | 0.170 |
Vascular dementia | 6 | 0.9 | 25 | 3.0 | −2.1 (−3.5 to −0.6) | 0.33 (0.13–0.83) | 0.018 |
Censoring for stroke | |||||||
Overall dementia | 33 | 5.1 | 67 | 8.5 | −3.4 (−6.1 to −0.6) | 0.68 (0.45–1.03) | 0.072 |
Alzheimer’s disease | 29 | 4.5 | 45 | 5.7 | −1.2 (−3.6 to 0.1) | 0.89 (0.56–1.41) | 0.610 |
Vascular dementia | 3 | 0.5 | 13 | 1.6 | −1.2 (−2.3 to −0.1) | 0.33 (0.09–1.20) | 0.092 |
. | Number of events . | Event rate . | Number of events . | Event rate . | Absolute rate difference per 1000 person-years (95% CI) . | Adjusted hazard ratioa (95% CI) . | P-value . |
---|---|---|---|---|---|---|---|
Ablation vs. medical therapy | |||||||
Ablation (N = 5863) | Medical therapy (N = 5863) | ||||||
Including stroke | |||||||
Overall dementia | 164 | 5.6 | 308 | 8.1 | −2.5 (−3.8 to −1.2) | 0.73 (0.58–0.93) | <0.001 |
Alzheimer’s disease | 120 | 4.1 | 189 | 5.0 | −0.9 (−1.9 to 0.1) | 0.77 (0.61–0.97) | 0.030 |
Vascular dementia | 36 | 1.2 | 85 | 2.2 | −1.0 (−1.7 to −0.4) | 0.50 (0.33–0.74) | <0.001 |
Censoring for stroke | |||||||
Overall dementia | 134 | 4.7 | 217 | 5.9 | −1.3 (−2.4 to −0.1) | 0.76 (0.61–0.95) | 0.015 |
Alzheimer’s disease | 106 | 3.7 | 140 | 3.8 | −0.1 (−1.1 to 0.8) | 0.91 (0.71–1.18) | 0.490 |
Vascular dementia | 22 | 0.8 | 51 | 1.4 | −0.6 (−1.1 to −0.1) | 0.60 (0.36–0.98) | 0.041 |
Ablation vs. AAD | |||||||
Ablation (N = 3612) | AAD (N = 3612) | ||||||
Including stroke | |||||||
Overall dementia | 101 | 5.7 | 183 | 7.9 | −2.1 (−3.8 to −0.5) | 0.74 (0.57–0.94) | 0.015 |
Alzheimer’s disease | 77 | 4.4 | 118 | 5.1 | −0.7 (−2.1 to 0.7) | 0.89 (0.66–1.19) | 0.420 |
Vascular dementia | 20 | 1.1 | 49 | 2.1 | −1.0 (−1.8 to −0.2) | 0.57 (0.34–0.95) | 0.031 |
Censoring for stroke | |||||||
Overall dementia | 83 | 4.9 | 133 | 6.0 | −1.1 (−2.6 to 0.4) | 0.82 (0.62–1.08) | 0.160 |
Alzheimer’s disease | 67 | 3.9 | 94 | 4.2 | −0.3 (−1.6 to 1.0) | 0.96 (0.69–1.32) | 0.790 |
Vascular dementia | 13 | 0.8 | 28 | 1.3 | −0.5 (−1.1 to 0.2) | 0.54 (0.28–1.04) | 0.067 |
Ablation vs. rate control only | |||||||
Ablation (N = 1273) | Rate control only (N = 1273) | ||||||
Including stroke | |||||||
Overall dementia | 41 | 6.2 | 102 | 12.1 | −5.9 (−9.1 to −2.8) | 0.57 (0.40–0.83) | 0.003 |
Alzheimer’s disease | 33 | 5.0 | 64 | 7.6 | −2.6 (−5.2 to 0.0) | 0.75 (0.49–1.14) | 0.170 |
Vascular dementia | 6 | 0.9 | 25 | 3.0 | −2.1 (−3.5 to −0.6) | 0.33 (0.13–0.83) | 0.018 |
Censoring for stroke | |||||||
Overall dementia | 33 | 5.1 | 67 | 8.5 | −3.4 (−6.1 to −0.6) | 0.68 (0.45–1.03) | 0.072 |
Alzheimer’s disease | 29 | 4.5 | 45 | 5.7 | −1.2 (−3.6 to 0.1) | 0.89 (0.56–1.41) | 0.610 |
Vascular dementia | 3 | 0.5 | 13 | 1.6 | −1.2 (−2.3 to −0.1) | 0.33 (0.09–1.20) | 0.092 |
Event rates are per 1000 person-years.
Adjusted for clinical variables (listed in Table 1) and competing risk of all-cause deaths.
AAD, antiarrhythmic drug; CI, confidence interval.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.